|
National Cancer Institute investigating trial outliers to resurrect ‘failed’ drugs
FierceBiotech The patient, who had advanced bladder cancer, experienced a complete response for 14 months to the drug combination everolimus (Afinitor) and pazopanib (Votrient) in a Phase I trial. In the trial, investigators recruited 9 patients with advanced solid … |
This KOL (Coal) Is LOL — Lots Of LaborStockhouseIndia will have used in that fiscal year about 125 million or more tons of the high-quality coal, mainly for power plants, cement plants, steel plants, and even individual villages and small towns. Vietn…
Military.com |
Airman Saves Mother’s Life with Organ Donation
Military.com NOT AIR FORCE BASE, N.D. — As she lay on the cold metal table in an operating room in Virginia, the profoundness of what she was about to do began to set in. Body shaking and vision narrowing, it dawned on her that in a few short hours she will have … |
|
EASL updates recommendations for HCV management
Healio Another key message in terms of special populations was that patients with cirrhosis or those who have or will undergo liver transplantation should receive treatments that are interferon-free. “My last point is that we have no data for hemodialysis … |
The Pharma Letter |
Emerging therapies for relapsed/refractory CLL/SLL expected to offer efficacy …
The Pharma Letter It is expected that these agents will be added to rituximab-containing regimens, such as bendamustine (Teva Pharmaceutical Industries’ Treanda, Mundipharma’s Ribomustin/Levact, Symbio Pharmaceuticals/Eisai’s Treakisym) in combination with rituximab, … |
|
Aberdeen Asia Pacific Equity
Hargreaves Lansdown However, in the team’s view, property prices will rise over the long term, and they have topped up positions on weakness, including City Developments and Hang Lung Properties. Many investors also focused on high-growth areas such as technology. The … |
Times of IndiaAmbareesh back, takes dig at RamyaTimes of IndiaRebel Star Ambareesh returned to Bangalore on Friday, after treatment for a lung condition in Singapore. The actor-minister was received by a large gathering of friends and near and dear one…
|
FDA grants breakthrough therapy status for Celladon’ heart failure treatment …
Pharmaceutical Business Review The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Celladon’s lead product candidate, Mydicar, for reducing hospitalisations for heart failure in NYHA class III or IV chronic heart failure patients who are NAb … FDA Grants “Breakthrough Therapy” Status for Gene Therapy to reduce Systolic …Next Big Future |
Brockville Recorder and Times |
Urgent need for liver transplant
Brockville Recorder and Times Since learning of her need for a liver transplant, Thake has connected with an Ottawa woman who underwent liver transplant surgery several years ago. “I’m so grateful, through her emails and her phone calls,. She’s been so supportive, having been … |
To be an organ donor, specific attitudes trump general support, study findsScience CodexIf people said they felt positive specifically about signing up as an organ donor they were much more likely to register than if they simply said they strongly supp…